Company: GEHC
Filing Date: 2025-10-29
Form Type: 10-Q
Source: 0001932393-25-000053
Chunk: 42

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-10-29
Form: 10-Q
Item: Item 1
Chunk 42
---
 compensation and benefits, All other current liabilities, Non-current compensation and benefits, and All other non-current liabilities in the Condensed Consolidated Statements of Financial Position. The activity related to our restructuring liabilities follows.Employee termination costsFacility and other exit costsTotalBalance at December 31, 2024$67 $18 $86 Charges59 3 62 Payments and other adjustments(48)(11)(59)Balance at September 30, 2025$78 $11 $89 

26

NOTE 15. EARNINGS PER SHARE

The numerator for both basic and diluted earnings per share (“EPS”) is Net income attributable to GE HealthCare. The denominator of basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, restricted stock units, and performance share units is reflected in the denominator for diluted EPS using the treasury stock method.Earnings Per ShareFor the three months ended September 30For the nine months ended September 30(In millions, except per share amounts)2025202420252024Numerator:Net income$464 $490 $1,552 $1,312 Net (income) loss attributable to noncontrolling interests(18)(19)(57)(40)Net income attributable to GE HealthCare$446 $470 $1,495 $1,272 Denominator:Basic weighted-average shares outstanding456 457 457 456 Dilutive effect of common stock equivalents1 2 1 2 Diluted weighted-average shares outstanding457 459 458 459 Basic earnings per share$0.98 $1.03 $3.27 $2.79 Diluted earnings per share0.98 1.02 3.26 2.77 Antidilutive securities(1)4 2 4 4 (1) Diluted earnings per share excludes certain shares issuable under share-based compensation plans because the effect would have been antidilutive.

NOTE 16. SUPPLEMENTAL FINANCIAL INFORMATION

CASH, CASH EQUIVALENTS, AND RESTRICTED CASH.As ofSeptember 30, 2025December 31, 2024Cash and cash equivalents(1)$4,005 $2,874 Short-term restricted cash22 16 Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Financial Position